More Evidence Tamoxifen, Other Meds Help Limit Breast Cancer’s Spread

A young woman having taking a mammogram, looking at the camera
This post was originally published on this site

This is prepended content.

THURSDAY, Oct. 6, 2016 (HealthDay News) — Treatment with tamoxifen or another class of drugs called aromatase inhibitors does cut breast cancer patients’ risk of developing cancer in their other breast, a new study finds.

Some breast cancers rely on estrogen to help them grow, and drugs like tamoxifen or the aromatase inhibitors (which include anastrozole) have long been prescribed to certain breast cancer survivors.

Tamoxifen blocks estrogen receptors in the breast cells to hamper cancer growth. Anastrozole stops estrogen production in fat tissue, which makes small amounts of the hormone.

According to background information in the new study, about 5 percent of breast cancer patients develop cancer in their other breast (contralateral breast cancer) within 10 years after their initial breast cancer diagnosis. Prior clinical trials had concluded that tamoxifen and aromatase inhibitors reduce this risk, but their impact on actual patient treatment was unclear.

The new study was led by Gretchen Gierach, of the U.S. National Institutes of Health, and involved almost 7,500 women diagnosed with invasive breast cancer between 1990 and 2008.

Most of the patients were white and their average age at diagnosis was nearly 61. Tamoxifen was used by 52 percent of the patients for an average of just over three years.

Aromatase inhibitors were used by nearly 26 percent of the patients. About half of this group took aromatase inhibitors with tamoxifen for a median of 2.2 years, and about half took aromatase inhibitors alone for a median of almost three years.

During just over six years of follow-up, 248 of the patients in the study were diagnosed with a cancer appearing in the previously unaffected breast.

However, the risk of this happening declined the longer patients took tamoxifen, Gierach’s team found. Compared to those who did not take the drug, current users had a 66 percent lower risk after four years of taking tamoxifen. Risk reductions were smaller but still significant at least five years after stopping tamoxifen therapy, the study authors noted in a news release.

Use of aromatase inhibitors without tamoxifen was also associated with reduced risk of cancer in the previously unaffected breast, the findings showed.

Overall, for every 100 patients who’d survived at least five years, using tamoxifen for at least four years was estimated to prevent three cases of tumors spreading to the previously unaffected breast over a decade, the researchers said. That finding was specific to women with what are known as estrogen receptor-positive tumors, where the cancer is sensitive to the hormone.

Gierach’s team believes the findings support recommendations that breast cancer survivors “complete the full course” of whichever medication (tamoxifen or aromatase inhibitor) they’ve been prescribed.

Two oncologists each called the new findings “reassuring.”

One is Dr. Stephanie Bernik, who is chief of surgical oncology at Lenox Hill Hospital in New York City. She believes that tamoxifen and aromatase inhibitors are potentially life-saving, so the new findings are welcome.

“Many women have side effects from the drugs and although these side effects are often minor, they need encouragement to continue using the drug,” Bernik explained. “With more evidence showing that in real-life settings tamoxifen and aromatase inhibitors help prevent recurrences, more women will continue to take the drug for longer periods of time.”

Dr. Nina D’Abreo directs the Breast Health Program at Winthrop-University Hospital in Mineola, N.Y. She believes the NIH trial confirms the benefits of the drugs as evidenced in prior studies, and may help dissuade some women from deciding to have the unaffected breast removed for preventive purposes.

D’Abreo said the study “also affirms that the duration of therapy matters, but even shorter use has benefits for the ‘real-world patient’ who cannot comply with the recommended five to 10 years.”

The findings were published online Oct. 6 in the journal JAMA Oncology.

SOURCES: Stephanie Bernik, M.D., chief, surgical oncology, Lenox Hill Hospital, New York City; Nina D’Abreo, M.D., medical director, Breast Health Program, and attending physician, department of oncology and hematology, Winthrop-University Hospital, Mineola, N.Y.; JAMA Oncology, news release, Oct. 6, 2016

News stories are provided by HealthDay and do not reflect the views of MedlinePlus, the National Library of Medicine, the National Institutes of Health, the U.S. Department of Health and Human Services, or federal policy.

© 2016, External_Author. All rights reserved.

About External_Author 26 Articles
When an author is not listed or imported into a curated cancer news story, the author is listed as, External_Author. Please see the original source of the article linked under the title for further information on the author.

Be the first to comment

Leave a Reply

Your email address will not be published.


*


Website Use Agreement

This post was originally published on this site

This is prepended content.

See Comments Policy Below

NOTICE. The Cancer News and Blog site (the “website”) is made up of many web pages and posts. The website is offered to you based on your acceptance without modification of the terms, conditions and notices contained herein (the “Website Use Agreement”). Your use of the website constitutes your agreement to all the terms and conditions stated herein.

(adsbygoogle = window.adsbygoogle || []).push({});

PERSONAL AND NON-COMMERCIAL USE LIMITATION. This website is for your personal and non-commercial use. You may not modify, copy, distribute, display, perform, reproduce, publish, license, create derivative works from, transfer, re-transmit, or sell any information, software, products or services obtained from the website. You may not use any computerized or automatic mechanism to access, extract and/or download any information from the website.

LINKS TO THIRD PARTY SITES. The website may contain links to websites controlled or offered by third parties. Cancer News and Blog disclaims liability for any information, materials, products or services posted or offered at any of the third party sites linked from the website. By creating a link to a third party website, Cancer News and Blog does not endorse or recommend any products or services offered or information contained at such linked website(s), nor is Cancer News and Blog liable for any failure of any products, information or services offered or advertised at such linked website(s).

NO UNLAWFUL OR PROHIBITED USE. As a condition for your use of the website, you agree that you will not use the website for any purpose that is unlawful or prohibited by the Website Use Agreement or Privacy Policy. The website is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to local law or regulation. You may not use the website in any manner which could damage, disable, overburden or impair the website, the networks connected to the website, or interfere with any other party’s use and enjoyment of the website. You may not attempt to gain unauthorized access to the website, other accounts, computer systems or networks connected to the website by any means, including without limitation, hacking or password mining. You may not obtain or attempt to obtain any materials or information through any means not intentionally made available through the website.

MATERIALS PROVIDED. Cancer News and Blog does not claim ownership of any materials you provide to Cancer News and Blog (including feedback and suggestions) or post, upload, input, provide or submit to the website for review by members of the general public, or by members of any public or private group (each a “Submission”). However, by posting, uploading, inputting, providing or submitting your Submission you are granting Cancer News and Blog and its agents permission to use your Submission in connection with Cancer News and Blog operation of the website and its other businesses, including without limitation, the right to copy, distribute, transmit, publicly display, reproduce, edit, translate and reformat your Submission, and to publish your name in connection with your Submission, all without the payment of compensation to you in respect of any such use of your Submission. You warrant and represent that you own, or otherwise control, all of the rights to your Submission, including without limitation, the rights necessary for you to post, upload, input, provide or submit your Submission.

NO RIGHT TO REDISTRIBUTE WEBSITE MATERIALS. You agree that you will not redistribute, copy, amend, or commercially exploit any materials found on the website without Cancer News and Blog’s express written permission, which permission may be withheld in Cancer News and Blog’s sole discretion and/or that of its owner.

NO MEDICAL DIAGNOSIS OR OPINIONS ARE GIVEN ON THIS WEBSITE. The information on this website is solely for informational purposes. IT IS NOT INTENDED TO PROVIDE MEDICAL ADVICE. Neither CancerNewsandBlog.com, Vernon Carré, the author of any page or post on this website take responsibility for any possible consequences from any treatment, procedure, exercise, dietary modification, action or application of medication which results from reading or following the information contained anywhere on this website, including the comments made by visitors and authors displayed in the Comments section of blog posts and pages, as well as in the research or news feeds presented on the website. The publication of this information does not constitute the practice of medicine, and this information does not replace the advice of your physician or other health care provider. Before undertaking any course of treatment, the reader must seek the advice of their physician or other health care provider. Failure to do so could result in permanently harming your health up to and including death. This website, its owner and any writers or authors on this website assume no risk or liability for the use or misuse of any of the information presented or discussed on this website.

Before engaging in any complementary medical technique, including the use of natural or herbal remedies, you should be aware that many of these techniques have not been evaluated in scientific studies.  Use of these remedies in connection with over the counter or prescription medications can cause severe adverse reactions. Often, only limited information is available about their safety and effectiveness. Each state and each discipline has its own rules about whether practitioners are required to be professionally licensed. If you plan to visit a practitioner, it is recommended that you choose one who is licensed by a recognized national organization and who abides by the organization’s standards. It is always best to speak with your primary health care provider before starting any new therapeutic technique.

PRODUCTS AND INFORMATION. For your convenience, Cancer News and Blog may make available on the website products for purchase, use and/or download (the “Products“) and information (“the Information”). Cancer News and Blog does not make any assurances with regard to the accuracy of the results or output that derives from such use of any such Products or Information. The Products and Information are copyrighted works of Cancer News and Blog, Vernon Carré and/or its suppliers, and are protected by copyright law and international treaty provisions. If a Product is accompanied by a use agreement, your use of that Product is governed by the terms of such use agreement, and you must agree to the terms and conditions of such use agreement in order to use such Product. If a Product is not accompanied by a license agreement, Cancer News and Blog hereby grants to you a revocable, personal, non-transferable license to use such Product in accordance with this Website Use Agreement and for no other purpose. Without limiting the foregoing, any reproduction, redistribution, reverse engineering or decompilation of the website or the Products or Information is expressly prohibited by law, unless such action is expressly permitted by the accompanying license agreement, and may result in severe civil and criminal penalties. You agree not to redistribute the Products or Information, nor to export or re-export the Products or Information, directly or indirectly, to any countries that are subject to USA export restrictions. You may not use the Products or Information to defame, abuse, harass, threaten or otherwise violate the legal rights of others. You may not use the Products or Information in association with the sale of any service or product which is discriminatory, obscene, defamatory, indecent or unlawful, or which in the reasonable opinion of Cancer News and Blog would reflect negatively upon the reputation of Cancer News and Blog, Vernon Carré, the website, the Products or the Information.

LIABILITY DISCLAIMER. THE TOOLS, RESOURCES, WEBSITE AND ANY CONTENT OR SOFTWARE CONTAINED THEREIN OR ACCESSIBLE THEREFROM, ARE PROVIDED “AS IS”. EXCEPT TO THE EXTENT REQUIRED BY APPLICABLE LAW, CANCER NEWS AND BLOG MAKES NO WARRANTIES OR REPRESENTATIONS OF ANY KIND REGARDING: (A) THE UP-TO-DATENESS, ACCURACY, TIMELINESS OR COMPLETENESS OF ANY INFORMATION CONTAINED WITHIN OR AVAILABLE THROUGH THE USE OF THE TOOLS, RESOURCES, LINKS, BLOG OR WEBSITE; (B) THE RESULTS OBTAINED FROM THE USE OF THE TOOLS, RESOURCES, LINKS, BLOG OR WEBSITE; AND (C) ANY INFORMATION PROVIDED BY THIRD PARTIES AND ACCESSIBLE ON OR THROUGH THE USE OF THE TOOLS, RESOURCES, LINKS, BLOG OR WEBSITE. EXCEPT TO THE EXTENT REQUIRED BY APPLICABLE LAW, CANCER NEWS AND BLOG: (A) DISCLAIMS ANY EXPRESS OR IMPLIED WARRANTIES AND CONDITIONS, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES AS TO NON-INFRINGEMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE; AND (B) DOES NOT WARRANT THAT THE TOOLS, RESOURCES, LINKS, BLOG OR WEBSITE OR ANY CONTENT THEREIN WILL BE UNINTERRUPTED OR ERROR FREE, OR THAT DEFECTS WILL BE CORRECTED.

THE USE OF THE PRODUCTS, INFORMATION, TOOLS, LINKS, BLOG POSTS AND WEBSITE IS AT YOUR OWN RISK, AND YOU ASSUME FULL RESPONSIBILITY FOR USING THE PRODUCTS, INFORMATION OR WEBSITE, OR DOWNLOADING ANY CONTENT THEREON. EXCEPT TO THE EXTENT THAT LIABILITY UNDER ANY APPLICABLE LAW OR REGULATION CANNOT BE EXCLUDED: (A) CANCER NEWS AND BLOG IS NOT LIABLE FOR HARM, LOSS OR DAMAGE OF ANY KIND WHATSOEVER ARISING AS A RESULT OF INFORMATION, RECOMMENDATIONS OR PRICES PUBLISHED ON OR FURNISHED THROUGH THE PRODUCTS, INFORMATION OR WEBSITE, OR ANY ERRORS OR OMISSIONS OF THE PRODUCTS, INFORMATION, TOOLS, LINKS, BLOG POSTS OR WEBSITE; (B) CANCER NEWS AND BLOG SHALL HAVE NO LIABILITY ARISING FROM INFORMATION PUBLISHED ON OR FURNISHED THROUGH THE PRODUCTS, INFORMATION, TOOLS, LINKS, BLOG POSTS OR WEBSITE; AND (C) UNDER NO CIRCUMSTANCES SHALL CANCER NEWS AND BLOG OR ITS OFFICERS, DIRECTORS, EMPLOYEES, VERNON CARRÉ , GUEST AUTHORS, AGENTS, VENDORS, SUPPLIERS OR DISTRIBUTORS BE LIABLE UNDER THIS AGREEMENT TO YOU OR ANY THIRD PARTY FOR ANY DEATH OR INDIRECT, SPECIAL, INCIDENTAL, PUNITIVE OR CONSEQUENTIAL LOSS OR DAMAGES OR ANY OTHER SIMILAR DAMAGES UNDER ANY THEORY OF LIABILITY (WHETHER IN CONTRACT, TORT, STRICT LIABILITY OR ANY OTHER THEORY), THAT ARE DIRECTLY OR INDIRECTLY ATTRIBUTABLE TO THE USE OF, OR THE INABILITY TO USE, THE PRODUCTS, INFORMATION, TOOLS, LINKS, BLOG POSTS, WEBSITE, OR ANY CONTENT CONTAINED THEREON, EVEN IF CANCER NEWS AND BLOG HAS BEEN INFORMED OF THE POSSIBILITY THEREOF. IF YOU ARE DISSATISFIED WITH ANY PRODUCTS, INFORMATION, OR ANY PORTION OF THE WEBSITE, OR WITH ANY OF THESE WEBSITE USE AGREEMENTS, YOUR SOLE AND EXCLUSIVE REMEDY IS TO DISCONTINUE USE OF THE PRODUCTS, INFORMATION, TOOLS, LINKS, BLOG POSTS AND WEBSITE.

INDEMNITY. You agree to indemnify and hold Cancer News and Blog, its owner(s), its parent, subsidiaries, affiliates, directors, officers and employees, harmless from any claim, demand, or damage, including reasonable attorneys’ fees, asserted by any third party or arising out of your use of, or conduct on, the website.

COPYRIGHT. The website, news feeds, tools, resources, links, blog posts and downloadable files are protected by copyright law and international treaty provisions and may not be copied or imitated in whole or in part. No logo, trademark, graphic or image from the website may be copied or re transmitted without the express written permission of Cancer News and Blog.

GENERAL. Your use of the website shall be governed by all applicable Federal laws of the United States of America and the laws of the States of North Carolina, Virginia and California, where the website is produced and/or hosted. Certain sections or pages of the website may contain separate terms or conditions. In the event of a conflict, the additional terms and conditions of this Website Use Agreement will govern for those sections or pages. Your agree that your use of the website will not create any joint venture, partnership, employment or agency relationship between you and Cancer News and Blog. If any part of this Website Use Agreement is determined to be invalid or unenforceable pursuant to applicable law including but not limited to the warranty disclaimers and liability limitations set forth above, then the invalid or unenforceable provision will be deemed superseded by a valid and enforceable provision that most closely matches the intent of the original provision and the remainder of this Website Use Agreement shall continue in effect.

MODIFICATION OF THESE AGREEMENTS OF USE. Cancer News and Blog reserves the right to change this Website Use Agreement without notice. You are responsible for regularly reviewing these Website Use Agreement terms. Your continued use of the website constitutes your agreement to all such Website Use Agreements listed in this Website Use Agreement.

Comments Policy

Cancer News and Blog welcomes your comments about its Blog Posts and Pages. However, the website reserves the right to deny the posting of comments on the web site that are considered spam, offensive, distasteful, discourteous, promotional or which are not specific to the location or post where they are posted. Comments that include ethnic slurs or personal insults, obscenities, off-topic comments or any conduct that are not acceptable to web admins who approve them will not be accepted. Comments approved, rejected or later removed will be done at the sole discretion of the web admins. In addition, any violation of the Comments Policy may result in the immediate banning of offender from the website and its use.

Neither Caner News and Blog, Vernon Carré or Guest Authors accept responsibility or liability for the authenticity, correctness, accuracy, completeness, use or any resulting harm (including death) to visitors or readers as a result of the information submitted by visitors or staff in the comments or replies to the comments which are posted and approved on the Cancer News and Blog website. Please see the NO MEDICAL DIAGNOSIS OR OPINIONS ARE GIVEN ON THIS WEBSITE section in the Web Use Agreement, above.

All comments submitted will be reviewed and approved web admins. Please allow up to 48 hours for your comment to be posted.

Minors should seek permission from their parents or guardians before posting any comment. This website and its owner assumes no responsibility or liability for the actions of any person, adult or child,  making comments in which they might purposefully or inadvertently cause themselves vulnerable or at risk personally, financially or in any other way due to a comment made on this website.

By submitting a comment, you are agreeing to comply with all applicable local, state, national and international laws, rules and regulations. By submitting your comment, you grant Cancer News and Blog and Vernon Carré a worldwide, non-exclusive, royalty-free license to reproduce, publish and distribute the comment. Questions or comments not related to a news article may be submitted via e-mail using this link.

© 2016, External_Author. All rights reserved.

X

Click now and download the free HACKER'S HUNDRED important cancer links every new and current cancer patient needs.

¤